We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Real Time, Non-Invasive Breath Test for COVID-19 Could Provide Results Within Seconds

By LabMedica International staff writers
Posted on 18 Dec 2020
Researchers are developing a real time, non-invasive breath test for COVID-19 that would provide results within seconds instead of days or weeks, and the initial data analysis of their research has shown great promise.

Mercyhealth (Rockford, IL, USA) and RJ Lee Group Inc. (Monroeville, PA, USA) recently concluded COVID-19-related research that utilizes a cutting-edge spectroscopic breath analyzer (BA), which allows experts to examine the compounds in exhaled breath associated with infection. This study is one of the world’s largest spectroscopic studies of breath in patients with COVID-19. Individuals being tested for COVID-19 using the gold standard nasopharyngeal swab test (or PCR) participated in the study which is one of the world’s largest spectroscopic studies of breath in patients with COVID-19.

Illustration
Illustration

The comparison between the PCR and the BA has been encouraging to-date. While the data continues to be examined, so far it has shown significant promise, as the test shows about 85% sensitivity and 85% specificity. This test is attractive to medical providers, researchers and patients as the results are obtained in less than a minute. The researchers now plan to conduct similar studies at other hospitals and to reach out to the FDA for approval for its use as a rapid reliable screening tool.

“This is truly a novel approach to COVID testing, as it’s neither targeting antigen or antibodies, but rather physiologic changes of infection,” said Jonathan Wistrom, a scientific consultant for RJ Lee Group and operator of Practical Sustainability, a chemistry consulting firm based in Maryville, MO.

“Results to-date have shown we can confidently identify those patients who are truly sick with COVID-19. The challenge remains in those who test positive by PCR and negative by breath test and trying to figure out what that means, added Dr. Christopher Wistrom, emergency medicine physician at Mercyhealth.

Related Links:
Mercyhealth
RJ Lee Group Inc.



New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
Automated Blood Typing System
IH-500 NEXT
New
Silver Member
Benchtop Image Acquisition Device
Microwell Imager
New
Herpes Virus Test
Human Herpes Virus (HHV-6) Real Time PCR Kit

Latest COVID-19 News

New Immunosensor Paves Way to Rapid POC Testing for COVID-19 and Emerging Infectious Diseases

Long COVID Etiologies Found in Acute Infection Blood Samples

Novel Device Detects COVID-19 Antibodies in Five Minutes